Celldex Therapeutics Inc — Cash Flow (NASDAQ:CLDX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 40.4 M60.9 M103.7 M107.3 M157.8 M210.94 M 210.94 M Cash from investing activities 98.22 M216.16 M89.94 M105.78 M290.13 M209.07 M 209.07 M Cash from financing activities 171.23 M272.37 M4.08 M218.46 M441.45 M2.39 M 2.39 M Free cash flow 38.85 M59.65 M101.87 M105.48 M155.88 M208.23 M 208.23 M

Haberler

Celldex kronik ürtiker tedavisi için Faz 2 verilerini sundu

Celldex presents phase 2 data for chronic urticaria treatment

Celldex Therapeutics Stock Earns 88 RS Rating

Celldex Therapeutics kazancı $0,21 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Celldex Therapeutics earnings missed by $0.21, revenue fell short of estimates

Celldex Therapeutics hissesi 30,66 dolarda 52 haftalık zirve yaptı

Celldex Therapeutics stock hits 52-week high at 30.66 USD

Stifel, Celldex Therapeutics hissesi için hedef fiyatını korudu

Stifel reiterates Celldex Therapeutics stock rating on trial progress

Celldex, CSU tedavisi için Faz 3 kaydını planın önünde tamamladı

Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule

Cantor Fitzgerald, Celldex’in Overweight notunu ve 67,00 dolar hedef fiyatını yineledi